Acute Exacerbations of Interstitial Lung Disease: Evolving Perspectives on Diagnosis and Management
Fibrosis · 2024
DOI: 10.70322/fibrosis.2024.10008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fibrosis, 2024. Verfasst von Carlo Arevalo und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben.
Abstract (Originalsprache)
Interstitial lung diseases (ILDs) are a heterogeneous group of chronic lung diseases caused by several potential etiologies but for many, the cause of a given ILD remains unknown. Accurate epidemiologic data are hard to find because of varying definitions, overlapping characteristics once thought to be unique to specific diseases, and ongoing changes in how ILDs are diagnosed and managed. In addition, there are significant variations in prevalence among different geographic populations, likely reflecting a combination of genetic and environmental differences. Certain risk factors, including exposure to cigarette smoke or environmental toxicants (asbestos, silica, fracking, coal dust, and air pollution), genetic mutations, and single nucleotide polymorphisms, have all been associated with developing interstitial lung disease. Due to the availability of high-resolution computed tomography (CT) scans, earlier and broader recognition of subtle imaging changes, and an aging worldwide population, the incidence and prevalence of ILDs are increasing. While a given cause of particular interstitial lung disease may vary, patients often experience breathlessness and a non-productive cough due to impaired alveolar gas exchange. Patients with ILD are prone to the development of acute exacerbations, marked by acute or chronic respiratory failure because of an acute exacerbation of the underlying lung disease. In this review, we discuss the definition of an acute exacerbation and comment on what is known about the underlying pathophysiology in exacerbations of idiopathic pulmonary fibrosis and other ILDs. We also emphasize the similarities in the clinical presentation of the acute exacerbations regardless of the underlying ILD, highlight key prognostic features of the diagnosis, and underscore the importance of interdisciplinary management of acute interstitial lung disease exacerbations.
Zitieren
APA
Arevalo, C., & Nagel, D. J. (2024). Acute Exacerbations of Interstitial Lung Disease: Evolving Perspectives on Diagnosis and Management. Fibrosis. https://doi.org/10.70322/fibrosis.2024.10008
Vancouver
Arevalo C, Nagel DJ. Acute Exacerbations of Interstitial Lung Disease: Evolving Perspectives on Diagnosis and Management. Fibrosis. 2024. doi:10.70322/fibrosis.2024.10008
BibTeX
@article{Arevalo2024,
author = {Arevalo, Carlo and Nagel, David J.},
title = {Acute Exacerbations of Interstitial Lung Disease: Evolving Perspectives on Diagnosis and Management},
journal = {Fibrosis},
year = {2024},
doi = {10.70322/fibrosis.2024.10008}
}
EUVIMED